Endocrinology, Vol 123, 2506-2513, Copyright © 1988 by Endocrine Society

ARTICLES

Progestin-mediated changes in progesterone receptor forms in the normal human endometrium

PD Feil, CL Clarke and PG Satyaswaroop
Department of Obstetrics and Gynecology, Milton S. Hershey Medical Center, Pennsylvania State University, Hershey 17033.

Monoclonal antibodies to the human progesterone receptor (PR) were used to detect changes in PR form during the menstrual cycle. In proliferative phase samples, two PR proteins with mol wt (Mr) of 116,000 and 81,000 were detected on protein blots probed with anti-PR monoclonal antibodies. The 116,000 Mr protein was comprised of triplet isoforms, while the 81,000 Mr protein was a singlet. By contrast, protein blot analysis of secretory phase samples revealed a doublet isoform at 116,000 Mr and an 81,000 Mr singlet. Organ culture of human endometrium was used to mimic these changes in PR form in vitro. Although the triplet to doublet conversion was not realized in organ culture, time- and dose-related changes in PR form were achieved which were similar to the in vivo state. Furthermore, these changes preceded the progestin-mediated induction of the enzyme estradiol dehydrogenase in parallel cultures, demonstrating that this is a useful system in which to study the relationship between receptor modulation and initiation and maintenance of biological response.

This article has been cited by other articles:

				R. O. Burney, S. Talbi, A. E. Hamilton, K. C. Vo, M. Nyegaard, C. R. Nezhat, B. A. Lessey, and L. C. Giudice Gene Expression Analysis of Endometrium Reveals Progesterone Resistance and Candidate Susceptibility Genes in Women with Endometriosis Endocrinology, August 1, 2007; 148(8): 3814 - 3826. [Abstract] [Full Text] [PDF]

				J. K. Richer, B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells J. Biol. Chem., February 8, 2002; 277(7): 5209 - 5218. [Abstract] [Full Text] [PDF]

				G. E. Hale, C. L. Hughes, and J. M. Cline Endometrial Cancer: Hormonal Factors, the Perimenopausal ""Window of Risk,"" and Isoflavones J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 3 - 15. [Abstract] [Full Text] [PDF]

				P. A. Mote, R. L. Balleine, E. M. McGowan, and C. L. Clarke Colocalization of Progesterone Receptors A and B by Dual Immunofluorescent Histochemistry in Human Endometrium during the Menstrual Cycle J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2963 - 2971. [Abstract] [Full Text]

				Y. G. Shanker and A. Jagannadha Rao Progesterone receptor expression in the human placenta Mol. Hum. Reprod., May 1, 1999; 5(5): 481 - 486. [Abstract] [Full Text] [PDF]

				C. Yeates, S. M. N. Hunt, R. L. Balleine, and C. L. Clarke Characterization of a Truncated Progesterone Receptor Protein in Breast Tumors J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 460 - 467. [Abstract] [Full Text]

				C. L. Bethea and A. A. Widmann Differential Expression of Progestin Receptor Isoforms in the Hypothalamus, Pituitary, and Endometrium of Rhesus Macaques Endocrinology, February 1, 1998; 139(2): 677 - 687. [Abstract] [Full Text] [PDF]

				J. D. Graham and C. L. Clarke Physiological Action of Progesterone in Target Tissues Endocr. Rev., August 1, 1997; 18(4): 502 - 519. [Abstract] [Full Text] [PDF]

				L. Denner, N. Weigel, B. Maxwell, W. Schrader, and B. O'Malley Regulation of progesterone receptor-mediated transcription by phosphorylation Science, December 21, 1990; 250(4988): 1740 - 1743. [Abstract] [PDF]